Home › Dysbiosis › NCT05288790
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Who can join
Ages 18 to 89 · All sexes
Full eligibility criteria
Inclusion Criteria: * HIV infected Exclusion Criteria: * Not fluent in English
About the study
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.
What is being tested
- Probiotic (dietary supplement)
- Placebo (dietary supplement)
Sponsor: Vanderbilt University Medical Center · Participants: 250 · Started: Sep 18, 2023
Contact the study team
- Grace Wallace, BS · Phone: 615-936-5356
- Emily Smith, MPH · Phone: 6158757253
Official record on ClinicalTrials.gov — NCT05288790
Locations in the U.S.
| Tennessee | Vanderbilt University Medical Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.